Sean Ramos

So FDA tries to come out and say, hey, guys, we're really worried about these peptides.

We're going to say maybe don't.

And then everyone says, but I want to and goes online to China, gets them.

Sometimes they come disguised in the mail and uses them anyway.

Surely that isn't the system we want.

And the implication is that Robert Fluoride Kennedy Jr.

wants to do something about it.

Okay, so RFK wants to do something about this.

He is not the head of the Food and Drug Administration.

When should we expect some decisive action to be taken on peptides in this country?

How soon is it, do you think, before we see like the next GLP-1 situation here in peptide town?

Because it feels like insulin, pretty big deal.

All these weight loss drugs, pretty big deal.

And then there's like a lot of fringy stuff going on that Ezra mentioned and that you talked about too.

Is it only a matter of time before we see the next huge peptide trend?

Or do you think this is like a passing fad?

But one thing that feels true of like our current experience as a society with GLP-1s right now and what Ezra wrote about with his experience just trying a bunch of stuff out is that like we're all just guinea pigs right now until the government figures this out or even once they do it feels like.

Read Lauren Gardner at politico.com.

Find Miles Bryan, Danielle Hewitt, Amina Alsadi, David Tadishore, Patrick Boyd, and Andrea Lopez Cruzado at vox.com.

This is Today Explained.